RARE-42. PRIMARY INTRACRANIAL SARCOMA WITH <i>DICER1</i>-MUTATION - TREATMENT RESULTS OF A NEW MOLECULAR ENTITY
Rosdali Díaz(Instituto Nacional de Enfermedades Neoplásicas), Juan Luis Garcı́a(Universidad de Salamanca), Antonio Wachtel Aptomizer, Gustavo R. Sarria(University of Bonn), Luis Pacheco Ojeda(Hospital Metropolitano), Andreas von Deimling(German Cancer Research Center), Jimena Ponce, Raymundo Sernaque(Instituto Nacional de Enfermedades Neoplásicas), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Ulrich Schüller(Universität Hamburg), Tatiana Negreiros(Instituto Nacional de Enfermedades Neoplásicas), Martin Mynarek(Universität Hamburg), Pamela García-Corrochano(Instituto Nacional de Enfermedades Neoplásicas), Christian Koelsche(Ludwig-Maximilians-Universität München), Danny Campos(Instituto Nacional de Salud del Niño), Pamela Mora(Instituto Nacional de Enfermedades Neoplásicas), Stefan Rutkowski(Universität Hamburg)
Cited by 0
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994